RPI Partner Claudine Szpilfogel is pleased to be moderating and part of an International panel at the upcoming ISPOR Latin America Summit 2021 to be held virtually September 30th and October 1st. Summit participants will be discussing new pathways for onco-hematology care in Latin America sharing different approaches to HTA assessment including learnings from the Canadian pCODR and pCPA process in Canada and the Cancer Drugs Fund from the UK. An example of the Columbian model and the improvement in onco-hematology treatment and controlling costs will be shared.
Claudine is thrilled to be presenting with Nicola Trevor, Head of Health Economics, Market Access and Reimbursement, Janssen UK and Dr. Miguel Alberto Amézquita Delgado, CEO at inValue Health Solutions and President of ISPOR Columbia Chapter. Thank you to Janssen Latin America for supporting this Symposium and their continued efforts in building capacity in enhancing the HTA assessment process.
